COMPASS THERAPEUTICS, INC.: 10-Q filed 2022-08-01
What COMPASS THERAPEUTICS, INC. reported in its quarterly report filed 2022-08-01 (fiscal Q2 2022): 37 published measures, 102 facts as tagged in accession 0001171843-22-005187.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2022-08-01
- Fiscal period
- fiscal Q2 2022
- Accession
- 0001171843-22-005187 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All COMPASS THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 140,256,000 | USD | |
| At 2021-12-31 | 153,757,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 13,328,000 | USD | |
| At 2021-12-31 | 13,679,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 126,928,000 | USD | |
| At 2022-03-31 | 134,490,000 | USD | |
| At 2021-12-31 | 140,078,000 | USD | |
| At 2021-06-30 | 28,875,000 | USD | |
| At 2021-03-31 | 33,471,000 | USD | |
| At 2020-12-31 | 39,945,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 26,238,000 | USD | |
| At 2021-12-31 | 144,514,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -8,494,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -15,656,000 | USD | 181 |
| 2022-01-01 to 2022-03-31 | -7,162,000 | USD | 90 |
| 2021-04-01 to 2021-06-30 | -55,804,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -63,223,000 | USD | 181 |
| 2021-01-01 to 2021-06-20 | -63,223,000 | USD | 171 |
| 2021-01-01 to 2021-03-31 | -7,422,000 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | -12,542,000 | USD | 181 |
| 2021-01-01 to 2021-06-20 | -11,544,000 | USD | 171 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 131,000 | USD | 181 |
| 2021-01-01 to 2021-06-20 | 424,000 | USD | 171 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 0 | USD | 181 |
| 2021-01-01 to 2021-06-20 | -3,750,000 | USD | 171 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | -105,734,000 | USD | 181 |
| 2021-01-01 to 2021-06-20 | -627,000 | USD | 171 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | -249,245,000 | USD | |
| At 2021-12-31 | -233,589,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 100,947,000 | shares | 91 |
| 2022-01-01 to 2022-06-30 | 100,903,000 | shares | 181 |
| 2021-04-01 to 2021-06-30 | 51,913,000 | shares | 91 |
| 2021-01-01 to 2021-06-30 | 51,582,000 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -0.08 | USD/shares | 91 |
| 2022-01-01 to 2022-06-30 | -0.16 | USD/shares | 181 |
| 2021-04-01 to 2021-06-30 | -1.07 | USD/shares | 91 |
| 2021-01-01 to 2021-06-30 | -1.23 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 0 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 0 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 13,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 13,000 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 1,850,000 | USD | |
| At 2021-12-31 | 2,243,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 3,018,000 | USD | 181 |
| 2021-01-01 to 2021-06-20 | 1,856,000 | USD | 171 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -8,987,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -16,169,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | -55,689,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -63,025,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 134,545,000 | USD | |
| At 2021-12-31 | 147,105,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 0 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 0 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 111,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 253,000 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 10,884,000 | USD | |
| At 2021-12-31 | 10,631,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 6,532,000 | USD | |
| At 2021-12-31 | 867,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 8,987,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 16,169,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 55,689,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 63,025,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 100,968,000 | shares | |
| At 2021-12-31 | 100,832,000 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | -512,000 | USD | |
| At 2021-12-31 | 0 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 3,541,000 | USD | |
| At 2021-12-31 | 4,089,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 3,495,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 7,021,000 | USD | |
| At 2021-12-31 | 7,269,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 5,171,000 | USD | |
| At 2021-12-31 | 5,026,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 320,000 | USD | |
| At 2021-12-31 | 320,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 3,301,000 | USD | |
| At 2021-12-31 | 8,775,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 2,527,000 | USD | |
| At 2021-12-31 | 2,591,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -8,494,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -15,656,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | -55,791,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -63,210,000 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -9,006,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -16,168,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | -55,804,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -63,223,000 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 3,125,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 5,891,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 2,166,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 4,798,000 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 400,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | 300,000 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 493,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 513,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | -102,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -185,000 | USD | 181 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 0 | USD | 181 |
| 2021-01-01 to 2021-06-20 | 226,000 | USD | 171 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 5,588,000 | USD | 181 |
| 2021-01-01 to 2021-06-20 | -502,000 | USD | 171 |
Inspect the source
- Entity
- COMPASS THERAPEUTICS, INC. / CIK 0001738021
- Captured
- 2026-09-21T17:25:31.387Z
- SEC response SHA-256
9e12579e6cc358373d81361bc3010028797ebc5f19754d98e9f8de6b08aa1269
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001738021.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))